Evidence map›Paper›PMID 26398588›Full record

ArticleACS applied materials & interfaces2015

Physical Characterization and Platelet Interactions under Shear Flows of a Novel Thermoset Polyisobutylene-based Co-polymer.

Jawaad Sheriff, Thomas E Claiborne, Phat L Tran, Roshni Kothadia, Sheela George, Yasushi P Kato, Leonard Pinchuk, Marvin J Slepian, Danny Bluestein

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. In Vitro Durability and Stability Testing of a Novel Polymeric Transcatheter Aortic Valve.ASAIO journal (American Society for Artificial Internal Organs : 1992) · 2020
    Article
  9. Article
  10. Article
  11. Principles of TAVR valve design, modelling, and testing.Expert review of medical devices · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jawaad SheriffDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Thomas E ClaiborneDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Phat L TranDepartment of Biomedical Engineering, University of Arizona , Tucson, Arizona 85721, United States.
Roshni KothadiaDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Sheela GeorgeDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Yasushi P KatoInnovia LLC , Miami, Florida 33186, United States.
Leonard PinchukInnovia LLC , Miami, Florida 33186, United States.
Marvin J SlepianDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Danny BluesteinDepartment of Biomedical Engineering, Stony Brook University , Stony Brook, New York 11794-8151, United States.
Stony Brook University · USInnovia (United States) · USUniversity of Arizona · US

Funding

Optimizing Cardiovascular Device Thromboresistance for Eliminating AnticoagulantsU01EB012487 · NIBIB · STATE UNIVERSITY NEW YORK STONY BROOK · PI BLUESTEIN, DANNY · 2010 to 2014
$6.9M
NIBIB NIH HHS 5U01EB012487−04NIBIB NIH HHS U01 EB012487
6 · The paper itself

Abstract

Over the years, several polymers have been developed for use in prosthetic heart valves as alternatives to xenografts. However, most of these materials are beset with a variety of issues, including low material strength, biodegradation, high dynamic creep, calcification, and poor hemocompatibility. We studied the mechanical, surface, and flow-mediated thrombogenic response of poly(styrene-coblock-4-vinylbenzocyclobutene)-polyisobutylene-poly(styrene-coblock-4-vinylbenzocylcobutene) (xSIBS), a thermoset version of the thermoplastic elastomeric polyolefin poly(styrene-block-isobutylene-block-styrene) (SIBS), which has been shown to be resistant to in vivo hydrolysis, oxidation, and enzymolysis. Uniaxial tensile testing yielded an ultimate tensile strength of 35 MPa, 24.5 times greater than that of SIBS. Surface analysis yielded a mean contact angle of 82.05° and surface roughness of 144 nm, which was greater than for poly(ε-caprolactone) (PCL) and poly(methyl methacrylate) (PMMA). However, the change in platelet activation state, a predictor of thrombogenicity, was not significantly different from PCL and PMMA after fluid exposure to 1 dyn/cm(2) and 20 dyn/cm(2). In addition, the number of adherent platelets after 10 dyn/cm(2) flow exposure was on the same order of magnitude as PCL and PMMA. The mechanical strength and low thrombogenicity of xSIBS therefore suggest it as a viable polymeric substrate for fabrication of prosthetic heart valves and other cardiovascular devices.

Indexed as

Biocompatible MaterialsBlood PlateletsFemaleHeart Valve ProsthesisHemodynamicsHumansMaleMaterials TestingPlatelet ActivationPlatelet AdhesivenessPolyenesPolymersStyrenesBiocompatible MaterialsPolyenespolyisobutylenePolymerspoly(styrene-b-isobutylene-b-styrene)Styreneshemodynamic shearing deviceparallel plate flow chamberpolymersSIBSthrombin

Identifiers

PMID26398588
PMCPMC4608843
OpenAlexW2461618802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.